| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-14 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-08 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |